![]() Henson JV, Varhabhatla NC, Bebic Z, et al.cdc.gov/diabetes/managing/managing-blood-sugar/a1c.html. Centers for Disease Control and Prevention. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. Petersen EA, Stauss TG, Scowcroft JA, et al.GLG survey on the complications and treatment of diabetic peripheral neuropathy. Current Strategies for the Management of Painful Diabetic Neuropathy. Staudt MD, Prabhala T, Sheldon BL, et al.Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Eterna™ SCS Implantable Pulse Generator Clinician's Manual. Proclaim™ SCS Implantable Pulse Generator Clinician's Manual. ‡ Indicates a third party trademark, which is property of its respective owner. Based off comparison to volumetric measurement of the following IPGs: Boston Scientific ‡ WaveWriter Alpha ‡ 16: 20.1 cc Medtronic ‡ Intellis ‡: 13.9 cc Nevro ‡ Omnia ‡: 26 cc Saluda ‡ Evoke ‡: 33cc. †† Smallest size determined by volume in cubic centimeters. Refer to the Instructions for Use for full details on the MR Conditional scan parameters. ¶ Combined data from comparative studies. ‖ Follow your physician's guidance for your current medication regimen, and do not make any changes to your medication usage without consulting with your healthcare provider. § The BurstDR™ stimulation mode has not been evaluated for effectiveness in the DPN population. Monitor your patients’ outcomes and make necessary adjustments to their medication regimen accordingly. † It is important to note that the use of spinal cord stimulation does not necessarily negate the need for a medication regimen. * Abbott SCS systems offer relief from chronic pain due to DPN by delivering traditional “tingling” tonic stimulation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |